2 Surefire Chip Stocks to Buy and Hold for the Next Decade

The piece highlights long-term structural growth in semiconductors driven by AI and increasing chip content across devices, citing Statista's projection of ~10% annual industry growth to $980 billion by 2029. It profiles Taiwan Semiconductor Manufacturing (market cap ~ $971B; share price doubled since 2022) with analysts expecting revenue +26% this year and +24% in 2025, ~50% revenue from high-performance chips and a 61% global foundry share, and annualized earnings growth estimates of ~26%. It also profiles Arm (market cap ~ $159B) — licensing model with high margins, revenue +39% YoY in the latest quarter and analysts projecting ~27% annualized earnings growth — positioning both firms to benefit from rising AI/data-center demand.

Analysis

Market structure: AI-driven demand disproportionately benefits advanced-node foundries (TSM) and ISA licensors (ARM) while pressuring legacy IDMs (INTC) and mature-node pure-players. TSMC's ~61% share and ARM's royalty model create durable pricing/earnings leverage: expect high-margin revenue mix (HPC/AI) to drive 20–30% revenue CAGR for winners through 2025–27, tightening available advanced-node capacity and lifting pricing power for ~18–36 months until new fabs come online.

Risk assessment: Key tail risks are geopolitical disruption around Taiwan (probability ~5–10% over 3 years), EUV export curbs delaying nodes, and regulatory attacks on ARM's royalty model; any one could compress multiples by 20–40% quickly. Immediate (days) risk is sentiment/earnings volatility; medium (6–12 months) is guidance reset; long-term (2–5 years) is capex-driven supply glut if too many fabs ramp simultaneously.

Trade implications: Favor concentrated growth exposure sized modestly — use LEAPs to capture multi-year upside while preserving capital; hedge single-name concentration with pair trades (long TSM vs short INTC) or buy ARM calls financed by selling short-dated calls to harvest elevated IV. Monitor utilization (>92%) and capex guidance changes as trade triggers; target 12–24 month horizons and re-evaluate at quarterly reports.

Contrarian angles: Consensus understates fragility from concentrated customer risk (NVDA + few hypers represent >20–30% of revenue for foundries/licensors) and overstates perpetual multiple expansion — historical GPU booms (2016–18) show rapid mean reversion once capacity expands. Watch for 2026–27 supply inflection that could flip winners into margin pressured names if capex overshoots demand.

Key Decisions for Investors

• Establish a 3% portfolio long in TSM (TSM) via 12–18 month call LEAPs or share purchase, with a protective 6–9 month 20% OTM put (size the put ~0.5% portfolio) to guard against geopolitical or node-ramp shocks; trim to 1.5% if TSM guidance misses revenue growth by >5% on next quarterly report.
• Establish a 2% portfolio directional long in ARM (ARM) using 12–24 month call spreads (buy LEAP call, sell 30–40% OTM call) to cap cost, and exit or cut 50% if ARM quarterly royalty growth falls below 20% YoY or if major licensee pricing pushback is announced within 90 days.
• Implement a pair trade: long TSM equal-dollar vs short INTC (INTC) equal-dollar sized to beta (target net market exposure ~0), hold 6–12 months; take profits if spread widens by 20% or closes if INTC announces >$10B in foundry-capex reallocation within 12 months.
• Tactical options: for event-driven upside (NVIDIA Blackwell, TSM capacity updates), buy 3–6 month call spreads on NVDA/TSM ahead of product cadence and finance by selling 30–45 day covered calls on ARM to capture IV; limit total options allocation to <2% portfolio to manage gamma risk.